Ironwood Pharmaceuticals said patient input will help shape future studies in short bowel syndrome with intestinal failure, following discussions at the Oley Fo

Ironwood Pharmaceuticals said patient input will help shape future studies in short bowel syndrome with intestinal failure, following discussions at the Oley Foundation conference. Prior survey data showed ending total parenteral nutrition was patients’ top therapy goal.